Jake Holdreith and Ronald Schutz Named 2018 “Life Sciences Stars” by LMG Life Sciences

September 27, 2018

Robins Kaplan LLP is pleased to announce that Jake Holdreith and Ronald Schutz have been named “Life Science Stars” by LMG Life Sciences. Additionally, the firm has been recommended as a top Hatch-Waxman patent litigation firm for generic pharmaceutical companies.

Holdreith leads the firm’s Health and Life Sciences Industry Group. “Jake is not just a lawyer, he is an advisor,” noted one client in LMG’s analysis of the award. “He has a knack for understanding not only the legal ramifications of litigation strategy, but also how they interplay with business strategy.”

Schutz is the managing partner of the New York office and a leading IP trial lawyer. His advocacy skills have been recognized by numerous organizations, including Chambers, Benchmark Litigation, Managing Intellectual Property, and The National Law Journal, among others.

This is the fifth year that Holdreith and Schutz have been recognized as “Life Science Stars.” Recipients were chosen based on nearly 1,000 interviews and surveys, including firm-wide surveys, interviews with individual attorneys and clients, and a review of public information.

Jake M. Holdreith


Managing Partner, Minneapolis Office
Member of Executive Board

Ronald J. Schutz


Immediate Past Chairman
Member of Executive Board

Related Publications

May 17, 2024
Warzone Clash: When Does a Video Game Title Cross the Line Into Trademark Infringement?
David Martinez, Navin Ramalingam - Los Angeles & San Francisco Daily Journal
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
March 2024
e-Commerce: Pitfalls and Protections
David Martinez, Zac Cohen - Los Angeles Lawyer
March 25, 2024
Endo Ventures Unlimited Co. v. Nexus Pharms. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 22, 2024
Mallinckrodt plc v. Airgas Therapeutics LLC
GENERICally Speaking Hatch Waxman Bulletin
Back to Top